The board of directors of biopharmaceutical company Merck (NYSE:MRK) declared a dividend of USD0.61 per share of the company's common stock for the second quarter of 2020, it disclosed on Tuesday.

Shareholders of record at the close of business as of 16 March 2020 will receive the dividend on 7 April 2020.

Merck said that for more than a century, it has been providing medicines and vaccines for the most challenging diseases.

The company delivers innovative health solutions such as prescription medicines, vaccines, biologic therapies and animal health products. It operates in more than 140 countries.